Cargando…

A Screened GPR1 Peptide Exerts Antitumor Effects on Triple-Negative Breast Cancer

The adipokine chemerin has been considered an important regulator of tumor immune surveillance. Chemerin recruits leukocytes through the receptor CMKLR1 to improve clinical outcomes of tumors and overall patient survival, but the role of GPR1 in tumors has not been widely investigated. Here, we foun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chen, Dai, Xiao-Yong, Cai, Jia-Xuan, Chen, Jie, Wang, Bao Bei, Zhu, Wen, Wang, Esther, Wei, Wei, Zhang, Jian V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508919/ https://www.ncbi.nlm.nih.gov/pubmed/33005727 http://dx.doi.org/10.1016/j.omto.2020.08.013

Ejemplares similares

Dezocine, An Opioid Analgesic, Exerts Antitumor Effects in Triple-Negative Breast Cancer by Targeting Nicotinamide Phosphoribosyltransferase
por: Xue, Chenyang, et al.
Publicado: (2021)

HSulf-1 and palbociclib exert synergistic antitumor effects on RB-positive triple-negative breast cancer
por: Chen, Fengxia, et al.
Publicado: (2020)

A Novel Fibromodulin Antagonist Peptide RP4 Exerts Antitumor Effects on Colorectal Cancer
por: Deng, Ting, et al.
Publicado: (2023)

KPT‐330 and Y219 exert a synergistic antitumor effect in triple‐negative breast cancer through inhibiting NF‐κB signaling
por: Wen, Tiantian, et al.
Publicado: (2023)

GPR110 promotes progression and metastasis of triple-negative breast cancer
por: Nam, Hye-Jung, et al.
Publicado: (2022)

LPM3770277, a Potent Novel CDK4/6 Degrader, Exerts Antitumor Effect Against Triple-Negative Breast Cancer
por: Qiu, Jiahao, et al.
Publicado: (2022)

Correction: GPR110 promotes progression and metastasis of triple-negative breast cancer
por: Nam, Hye-Jung, et al.
Publicado: (2022)

BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells
por: Rossi, Teresa, et al.
Publicado: (2023)

Domperidone Exerts Antitumor Activity in Triple-Negative Breast Cancer Cells by Modulating Reactive Oxygen Species and JAK/STAT3 Signaling
por: Shakya, Rajina, et al.
Publicado: (2023)

Inhibition of APE1 Expression Enhances the Antitumor Activity of Olaparib in Triple-Negative Breast Cancer
por: Jian, Dan, et al.
Publicado: (2022)

Coriloxin Exerts Antitumor Effects in Human Lung Adenocarcinoma Cells
por: Kuo, Yu-Hsuan, et al.
Publicado: (2022)

Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer
por: Andradas, Clara, et al.
Publicado: (2016)

USP53 Exerts Tumor-Promoting Effects in Triple-Negative Breast Cancer by Deubiquitinating CRKL
por: Liu, Yi, et al.
Publicado: (2023)

Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer
por: Cha, Jong-Ho, et al.
Publicado: (2022)

The nature of triple-negative breast cancer classification and antitumoral strategies
por: Kim, Songmi, et al.
Publicado: (2020)

Yiqi Formula Enhances the Antitumor Effects of Erlotinib for Treatment of Triple-Negative Breast Cancer Xenografts
por: Liao, Ming-juan, et al.
Publicado: (2014)

Pristimerin exerts antitumor activity against MDA-MB-231 triple-negative breast cancer cells by reversing of epithelial-mesenchymal transition via downregulation of integrin β3
por: Liu, Shiyue, et al.
Publicado: (2021)

Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor
por: Huang, Li, et al.
Publicado: (2011)

Targeting endogenous DLK1 exerts antitumor effect on hepatocellular carcinoma through initiating cell differentiation
por: Cai, Chun-Miao, et al.
Publicado: (2016)

Fenofibrate Exerts Antitumor Effects in Colon Cancer via Regulation of DNMT1 and CDKN2A
por: Kong, Rui, et al.
Publicado: (2021)

Juglone exerts antitumor effect in ovarian cancer cells
por: Fang, Fang, et al.
Publicado: (2015)

The role of GPR1 signaling in mice corpus luteum
por: Yang, Ya-Li, et al.
Publicado: (2016)

Antitumor efficacy of the Runx2-dendritic cell vaccine in triple-negative breast cancer in vitro
por: Tang, Mi, et al.
Publicado: (2018)

The development of activatable lytic peptides for targeting triple negative breast cancer
por: Zhao, Hui, et al.
Publicado: (2017)

Aloperine Exerts Antitumor Effects on Bladder Cancer in vitro
por: Zhang, Lijun, et al.
Publicado: (2020)

Fabrication of Ginsenoside-Based Nanodrugs for Enhanced Antitumor Efficacy on Triple-Negative Breast Cancer
por: Zuo, Shuting, et al.
Publicado: (2022)

Antitumor Activity of Noscapine in Combination with Doxorubicin in Triple Negative Breast Cancer
por: Chougule, Mahavir B., et al.
Publicado: (2011)

Pan-Cancer Analysis and Drug Formulation for GPR139 and GPR142
por: Kaushik, Aman Chandra, et al.
Publicado: (2021)

PCC0208018 exerts antitumor effects by activating effector T cells
por: Ge, Minmin, et al.
Publicado: (2019)

Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy
por: Girgert, Rainer, et al.
Publicado: (2012)

The GPR171 pathway suppresses T cell activation and limits antitumor immunity
por: Fujiwara, Yuki, et al.
Publicado: (2021)

TAK228 enhances antitumor activity of eribulin in triple negative breast cancer
por: Owusu-Brackett, Nicci, et al.
Publicado: (2019)

Antitumor activity of new chemical compounds in triple negative mammary adenocarcinoma models
por: Giolito, María V, et al.
Publicado: (2020)

Unraveling the Pivotal Network of Ultrasound and Somatic Mutations in Triple-Negative and Non-Triple-Negative Breast Cancer
por: Huang, Yunxia, et al.
Publicado: (2023)

Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol
por: Girgert, Rainer, et al.
Publicado: (2014)

Hydrogen sulfide and its donors: Novel antitumor and antimetastatic therapies for triple-negative breast cancer
por: Li, Haonan, et al.
Publicado: (2020)

The GPR18 Agonist PSB-KD-107 Exerts Endothelium-Dependent Vasorelaxant Effects
por: Kotańska, Magdalena, et al.
Publicado: (2021)

Novel GPR43 Agonists Exert an Anti-Inflammatory Effect in a Colitis Model
por: Park, Bi-Oh, et al.
Publicado: (2022)

Purple sweet potato anthocyanin exerts antitumor effect in bladder cancer
por: Li, Wei-Lin, et al.
Publicado: (2018)

Gambogenic Acid Exerts Antitumor Activity in Hypoxic Multiple Myeloma Cells by Regulation of miR-21
por: Liu, Ping, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lgevecpuop335q03omc806l4la